Ask the Pharmacist: Are Skeletal Muscle Relaxants Useful in Management of Chronic Pain?
4 MIN READ
Concern about mounting opioid overdoses continued in 2020, and found the workers’ compensation and auto casualty industries in search of ways to mitigate opioid risks while still addressing the pai
Ask the Pharmacist: Emergency Use Authorization
4 MIN READ
How Does Emergency Use Authorization Differ from Full Approval of a Treatment or Vaccine? The immediate and urgent changes that a global pandemic demands have proven to be an enormous cha
Expertise and a Strong Specialty Network are Critical in Helping Injured Workers Recover from Opioid Use Disorder
4 MIN READ
What’s become clear from years of combating opioid use disorders is that, for most patients, recovery is difficult and often protracted.
Silver Linings in 2020 [Video]
Watch Alex share some silver linings from 2020, with recommendations on how to leverage this year’s positive trends to help you find greater success.
Clinical Cannabis Considerations
3 MIN READ
It seems there is always something new to say when it comes to the hot topic of medical marijuana or “cannabis,” as it’s commonly referred to in clinical literature.
2020 in Hindsight: Clinical Trends and Predictions
We will all remember 2020 for its startling impact on everyday life, from new work norms to how we receive medical care. The workers’ compensation and auto casualty industries have grappled with work-from-home requirements, increased unemployment, telehealth adoption and additional challenges with patient care and recovery. When it comes to pharmacy care, the pandemic has brought forth some issues while placing others on the backburner. This review will examine how the COVID-19 pandemic has affected the industry from a pharmacy perspective and what trends we expect to influence 2021.
Specialty Medication Trends
1 MIN READ
Specialty medications, which are typically used to treat patients with complex, chronic conditions, continue to be a major area of pharmaceutical development and can have significant costs.